| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |